The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
9 pts

Opinion on  SanofiAventis (SNY)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Updated Clinical Trial and FDA Decision Calendars

Mar 17, 2009 06:14 PM GMT
Mikerun
Return Risk
+1.04% MID
Principal

Updated Clinical Trial and FDA Calendars

Below is a summary of updates to the www.BioMedReports.co <wbr> </wbr> m database of 243 entries included in the FDA and Clinical Trial Calendars.

http://biomedreports <wbr> </wbr> .com/fda-calendar.ht <wbr> </wbr> ml

The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 104 entries through today. The FDA Calendar includes the following information: company name, ticker, decision date, and description.

The Clinical Trial Calendar includes 139 entries as of today and encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k,
PMA , sNDA, sBLA filings), and pending re-submissions to the FDA for complete response rulings by the agency which require more information before an approval can be granted.

1.) MannKind Corp. (
MNKD ): Submitted NDA on 3/16/09 for FDA approval of AFRESA (insulin monomer human rDNA origin) Inhalation Powder and the AFRESA Inhaler for the treatment of adults with type 1 or type 2 diabetes mellitus for the control of hyperglycemia. The expected PDUFA decision date under a standard (10-month) review is 1/16/10 for what would be an ultra rapid-acting form of insulin (achieving peak levels within 12-14 minutes to mimic the normal physiological release of insulin in healthy individuals) that is delivered through an inhaler rather than the typical route of injection by a syringe.

2.) Sanofi-Aventis (
SNY ): Multaq (dronedarone) NDA (priority review) for atrial fibrillation (a type of irregular heartbeat) - 3/18/09 is the date for FDA Advisory Panel Meeting - original PDUFA date was 1/31/09.

Multaq should be approved for delaying symptoms of atrial fibrillation and reducing hospitalization, a U.S. drug reviewer said in a memo released on Monday. However, the company should not be allowed make claims that the drug, Multaq, decreases the risk of death, Food and Drug Administration reviewer Abraham Karkowsky said in the Feb. 17 memo prepared for an advisory panel that meets Wednesday 18-March.

3.) United Therapeutics Corp. (
UTHR ) said Monday it will likely face regulatory delays for the inhaled version (Tyvaso) of its injectable pulmonary hypertension drug Remodulin because of FDA concerns over patient instructions. The original PDUFA decision date was 4/30/09, but the company expects a possible dealy of "a few months", reflecting concerns by the agency over the instructions for using the nebulizer that delivers the drug.

4.) DURECT Corp. (
DRRX ) announced positive results from a 74 patient Phase IIb clinical trial conducted by Endo Pharma ( ENDP ) of TRANSDUR-Sufentanil, a proprietary seven day patch under development for the treatment of chronic pain. DRRX expects to follow a 505(b)2 pathway for regulatory approval, as previously discussed with the FDA. Effective 8/26/09, DRRX will receive the right to develop and commercialize TRANSDUR-Sufentanil in the U.S. and Canada from ENDP .

5.) Johnson & Johnson (
JNJ ) + Bayer (BAYRY.PK): A 5/30/09 PDUFA date is pending for a new blood thinner drug, Xarelto (Rivaroxaban), in the treatment of deep vein thrombosis and pulmonary embolism. Ahead of a Thursday 3/19/09 FDA Advisory Panel Meeting to review Xarelto, documents filed by the agency reflect concerns over increased bleeding and other potential long-term safety data (e.g. liver concerns).

6.) Cephalon (
CEPH ): Reported positive results from a Phase 2 clinical trial of Nuvigil as adjunctive therapy for treating major depressive disorder in adults with bipolar I disorder and plans to conduct Phase 3 trials for this indication. CEPH plans to launch Nuvigil, the longer-lasting isomer of modafinil (sold under brand name Provigil) during 3Q09, with a label that includes the following indications: to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work sleep disorder, also known as shift work disorder (SWD), and narcolepsy.


SNY:  This call was made on 03/17/09 @ $27.272
Rating:   Positive   $27.272 (03/17/09)
Closed:   03/20/2009 @ $27.44 (+0.62% in 3 days)


Comments (4)

Add Comment

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 414 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |

Arrow_up
Arrow_down
zhujing   N/A     1 point   commented 242 days ago reply

CD Case Calendars CD Case Calendars Wool Socks
Bathroom Box Bathroom Box Wool Scarf
Flashlight With Ruler Flashlight With Ruler Wooden Yo Yo
Laptop Laptop Wooden Whistle
Frosty Beer Mug Frosty Beer Mug Wooden Watch
Basketball Net Basketball Net Wooden USB Flash Drive
Hand Shake Calculator Hand Shake Calculator Wooden Umbrella
Lighting Lighting Wooden Toys
Reciprocating Shaver Reciprocating Shaver Wooden Tape Measure
Wine Decoration Wine Decoration Wooden Stapler
Dome Magnifier Dome Magnifier Wooden Skewers
Medical Adhesive Tape Medical Adhesive Tape Wooden Radio
Articulating Arm Mount Articulating Arm Mount Wooden Puzzle
Metal Card Metal Card Wooden Photo Frame
Novelty Stapler Novelty Stapler Wooden Photo Album
Electronics Department Electronics Department Wooden Pen Holder
USB Warmer Mouse Pad USB Warmer Mouse Pad Wooden Pen
iPod Speaker iPod Speaker Wooden Optical Mouse
Hanging Passport Hanging Passport Wooden Necklace
Car Cool Seat Cushion Car Cool Seat Cushion Wooden Money Bank
BBQ Branding Iron BBQ Branding Iron Wooden Mirror
Stadium Seat Stadium Seat Wooden Massager
Metal Vase Metal Vase Wooden Lighter
Skype Mouse Skype Mouse Wooden Lamp
LED Novelties LED Novelties Wooden Handle
Carabiner Measure Carabiner Measure Wooden Digital Photo Frame
Compass Magnifier Compass Magnifier Wooden Cup
World Cup Soccer Cup World Cup Soccer Cup Wooden Crafts
Kitchen Towel Kitchen Towel Wooden Coaster

Arrow_up
Arrow_down
kevin921   N/A     1 point   commented 181 days ago reply

lists the fast, easy to use FLV converter software which helps you both convert FLV to any video files with excellent images and sound quality and convert any video to FLV . You can put the most popular online .flv, .swf videos like YouTube, Metacafe, etc on your digital device, like psp, ipod, zune, Apple TV, iphone..just Free download these specially picked FLV Converter to complete the format conversion easily!
youtube converter is acutally a combination softare of YouTube Downloader + YouTune Player+ YouTube Converter, so it can convert online YouTube Video from video sites like Yahoo, Google, MySpace, CNN, PBS fluently. The built-in FLV converter lets you convert downloaded videos local FLV files to MP4, 3GP, WMV, AVI, MOV, MPG for your iPhone, iPod, Cell Phone, etc.
Have you had such experience that when you watch a video, there is a piece of music which you like it very much? If you want to keep the audio, you can FLV to MP3 converter file.
With YouTube to iTunes Converter, convert YouTube to iTunes can be never a problem. YouTube to iTunes Converter is such a powerful software that it can record streaming video from nearly all websites, such as Yahoo, Google, MySpace, CNN, PBS, etc are all supported. With the help of YouTube to iTunes, download streaming videos will never so difficult as you thought.
youtube to mp3 mac is an easy-to-use YouTube to MP3 Converer online, which can easily download the streaming video/music and then convert them to MP3 music for entertainment. Besides converting YouTube to MP3 for Mac, you can quickly convert local FLV files to MP3, AAC, WAV, M4A, etc.

Arrow_up
Arrow_down
moncler111   N/A     1 point   commented 174 days ago reply

Sacs Louis Vuitton ou la chasse paraphé produits est observée depuis les kilos principauxLesaca près les sacs LV Monogram Canvas dans le collège centré. vraimentreconnue peut êtred'acquérir un sac à conjointet jeunesse recommandations cru sur la façon de chasserfacteursCinquante Eole Eole BT, les suivants 55Keepall Louis, qui se composent de sacs à main en alternance significative et motos Cruiser quel'exquis plusieurs heures Alizé avec LVautres bagages. Louis Vuitton Speedy abordable pour n'importe quel montant dénombrables de nombreuses années maintenant ou à proximité de la découverte fondée en mouvementunesuperbe fournissent près de Lv bonnequi bagages Speedy. Mais, je accepter que ce pourrait être le monogramme LV à acheter probablement le plus enchanté par la production del'utilisation du support.

Abercrombie And Fitch y compris les hoodies Abercrombie, vestes Abercrombie, Abercrombiemanteaux, etc sont populaires partout dans le world.Doudoune Abercrombie Fitch pour les femmes sont enlacés conique et corps pour un look sophistiqué et élégant. Ils sont rembourrés pour la chaleur avec conçues avec des broderies fines pour donner un toucher doux. Le Helenfausse fourrure veste polaire et Helen Faux vestes en fourrure capuche ouatés sont très populaires auprès des femmes. Celeste doublé de fourrure vestes et blousons parka Rylie sont également populaires auprès des femmes. Vestes femmes viennent dans les couleurs traditionnelles comme le marron, olive, nef, blanc, crème, ainsi que dans les rouges et roses. Le logo est mis en évidence Abercrombie brodé sur le devant la plupart du temps.

Sacoche Louis Vuitton est l'un de vos possibilités les plus exceptionnels pour les composantsutilisés sac de chasse bags.The pour gagner, penser à la façon d'identifier l'allusion, est vraiment monogramme substance, une substance identifiée comme c'est ténacité ainsi que lacréation d'aucune différence si elles sont riches avantage brossé.L ce sac Vuitton Monogrammatériau est fondée sur des composants de chasse monogramme est considérée comme la diversification il arrive avec, qui font de créer applicationidéale utilisation de comme un«bagage» des conteneurs. diverses modificationssommeil d'autres, au sein d'exactement le système du centre consistent exactement les mêmes de la bande nue, sans aucun douteextrêmement minuscule quantité de sacs à main qui ont lieu à l'élaboration d'utilisation de la bande obtenue, comme un as face est sans doute offert par la fonte mélangée légèrement.posséder une marque de la marque de diamètre intérieur (le type qui tirent profit des compagnies aériennes pour les sacs de l'identité individuelle), les Sacs Louis Vuitton fera parmi l'un des efforts les plus utiles à dos, surtout pour tous ceux qui voyagez léger offre ".


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
SanofiAventis (SNY)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
84.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated SNY
Positive -13.88% Unilife Medical (UNIFF.PK) (UNI.AX) Poised for NASDAQ: UNIS Trading Debut
01/12/2010
9
Positive +0.67% Access Pharma (OTC: ACCP.OB): ProLindac Well Positioned as Improved, Safer Platinum Drug
01/07/2010
9
Positive +4.62% Unilife Medical (ASX: UNI.AX) (UNIFF.PK): Recent Sell-Off Unwarranted, Quick Rebound Likely
12/13/2009
10
Positive +11.50% Access Pharma CEO Interview: Updates and Outlook
08/29/2009
9
Positive +17.61% FDA Calendar Updates: POZN, AZN, SNY, CEPH, APPY, CYTR
06/30/2009
9
Positive +0.24% Access Pharma (OTC:ACCP): Low Valuation, Big Potential
05/06/2009
9
Positive +5.63% Unilife: Making Syringes Safer, Relocating to U.S.
03/31/2009
9
Positive +1.06% Updated Clinical Trial and FDA Decision Calendars
03/20/2009
9
Positive +2.07% Bullish on SNY ...
10/11/2008
0
Positive -19.05% Eli Lilly Sinks After Hours on Effient Delay
09/28/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch